Rinehart KL Jr, Stroshane RM. Biosynthesis of aminocyclitol antibiotics[J]. Journal of Antibiotics, 1976, 29(4)：319-353.
[2]
Huang F, Spiteller D, Koorbanally NA, et al. Elaboration of neosamine rings in the biosynthesis of neomycin and butirosin[J]. Chembiochem, 2007, 8(3)：283-288.
[3]
Mehta R, Champney WS. Neomycin and paromomycin inhibit 30S ribosomal subunit assembly in Staphylococcus aureus[J]. Current Microbiology, 2003, 47(3)：237-243.
[4]
Hu GF. Neomycininhibits the angiogenic activity of fibroblast and epidermal growth factors[J]. Biochem Biophys Res Commun, 2001, 287(4)：870-874.
Hosoya Y, Okamoto S, Muramatau H, et al. Acquisition of certain streptomycin-resistant(str)mutations enhances antibiotic production in bacteria[J]. Antimicrob Agents Chemother, 1998, 42(8)：2041—2047．
Waksman SA, Lechevalier HA. Neomin, a new antibiotic active streptomycin-resistant bacteria, including tuberculosis organisms[J]. Science, 1949, 109(3)：305-307.
[13]
Hu GF. Neomycin inhibits angiogenin-induced angiogenesis[J]. Proc Natl Acad Sci USA, 1998, 95(17)：9791-9795.
[14]
Chater KF, Bruton CJ. Resistance, regulatory and production genes for the antibiotic methylenonycin are clustered[J]. EMBO J, 1985, 4: 1893-1897.
